Breast Cancer and Internal Mammary Sentinel Nodes: A Meta-Analysis

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 209

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHB-1-1_003

تاریخ نمایه سازی: 24 خرداد 1400

Abstract:

Background: The management of internal mammary (IM) nodes in breastcancer lacks a well-defined consensus. Lymphoscintigraphy identifies up to onethirdof breast cancer patients with extra-axillary drainage, which is mainly locatedin the IMchain.Our aimin thismeta-analysis is to identify the lymphoscintigraphytechnique variables that effect IMnode identification.Methods: An internet database was utilized to review articles concerningsentinel nodes and breast cancer from ۱۹۹۳ through the end of ۲۰۱۱; ۷۴ articlesmet our inclusion criteria. The total number of patients included was ۲۲۹۵۹. Wegrouped the citations by injection location and injection material. We thenanalyzed the rate of identification of IM nodes according to these groupings andtheir subsets.Results: The overall IM identification rate using the random effect model was۹%. The injection location had the most significant impact on IM identificationrate; the deeper injections were associated with the highest rate of identification.Variation in IM identification was associated with the particle size of injectionmaterial; the smaller particle size group had a higher rate of identification.Increased dose of the tracer was also associated with increased identification rate.Conclusions: The use of smaller particle size tracers and a deeper injectionlocation achieve the highest IM identification rate. The dose of the tracer alsoincreased theidentification rate. These observations can help in the selection ofpatients for IM sentinel node biopsy, which can affect their prognosis andtreatment management.

Authors

Khaldoun Bekdache

University of Vermont, College of Medicine, Burlington,Vermont, United States of America

Takamaru Ashikaga

University of Vermont, College of Medicine, Burlington,Vermont, United States of America

Renato Valdes Olmos

Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

Owen Allah Ung

Royal Brisbane and Women’s Hospital, University of Queensland, Queensland, Australia

David Krag

University of Vermont, College of Medicine, Burlington,Vermont, United States of America